業績

{ 304件 }

Cho KY, Nakamura A, Oba-Yamamoto C, Tsuchida K, Yanagiya S, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.

Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
Diabetes & Metabolism Journal. 2019. PMID: 31769240

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Montemurro C*, Nomoto H*, Pei L*, Vongbunyong KE, Vadrevu S, Gurlo T, Butler AE, Subramaniam R, Ritou E, Shirihai OS, Satin LS, Butler PC, Tudzarova S. IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function. Nat Commun. 2019. PMID: 31213603 (*: joint first authors)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sekizaki T, Kameda H, Oba C, Cho KY, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation. Endocr J, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Miya A, Nakamura A, Kameda H, Nozu K, Miyoshi H, Atsumi T. Gitelman’s Syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report. Medicine, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y. The protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease, and type 2 diabetes. J Diabetes Investig in press. (PMID: 31026373)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Miyazaki T, Shirakawa J, Nagakura J, Shibuya M, Kyohara M, Okuyama T, Togashi Y, Nakamura A, Kondo Y, Satoh S, Nakajima S, Taguri M, Terauchi Y. Influence of timing of insulin initiation on long-term glycemic control in Japanese patients with type 2 diabetes: a retrospective cohort study. Intern Med, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Sato M, Miyoshi H, Nakamura A, Sumi N, Kamoshima H, Ono Y. Cross-cultural adaptation of the chronic illness resources survey in Japanese patients with diabetes. Jpn J Nurs Sci, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Omori K, Nakamura A, Miyoshi H, Takahashi K, Kitao N, Nomoto H, Kameda H, Cho KY, Takagi R, Hatanaka KC, Terauchi Y, Atsumi T. Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. Metabolism, in press (PMID: 31202833)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Yamauchi Y, Nakamura A, Takahashi K, Takase T, Yamamoto C, Yokota I, Atsumi T, Miyoshi H. Factors with remission of fatty liver in patients with type 2 diabetes treated with ipragliflozin. Endocr J, in press

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T.  Proinsulin is sensitive to reflect glucose intolerance. J Diabetes Investig in press. (PMID: 31222973)

  • 2019
  • 糖尿病・内分泌グループ
  • 欧文論文/原著